Philips Performancebridge Focal Point vulnerabilities

4 CVEs affecting Philips Performancebridge Focal Point, 0 known to be exploited (CISA KEV), with EPSS scores. Latest: CVE-2020-16220, published 2020-09-11.

Highest priority

Known exploited (CISA KEV) first, then by EPSS exploit probability.

CVE-2020-16216, published 2020-09-11. Medium severity, CVSS 6.5. EPSS: 0.7% chance of exploitation in the next 30 days. In IntelliVue patient monitors MX100, MX400-550, MX600, MX700, MX750, MX800, MX850, MP2-MP90, and IntelliVue X2 and X3 Versions N and prior, the product receives input or data but does not validate…
CVE-2020-16222, published 2020-09-11. High severity, CVSS 8.8. EPSS: 0.5% chance of exploitation in the next 30 days. In Patient Information Center iX (PICiX) Version B.02, C.02, C.03, and PerformanceBridge Focal Point Version A.01, when an actor claims to have a given identity, the software does not prove or…
CVE-2020-16228, published 2020-09-11. Medium severity, CVSS 6.4. EPSS: 0.4% chance of exploitation in the next 30 days. In Patient Information Center iX (PICiX) Versions C.02 and C.03, PerformanceBridge Focal Point Version A.01, IntelliVue patient monitors MX100, MX400-MX550, MX750, MX850, and IntelliVue X3 Versions…
CVE-2020-16220, published 2020-09-11. Medium severity, CVSS 4.3. EPSS: 0.3% chance of exploitation in the next 30 days. In Patient Information Center iX (PICiX) Versions C.02, C.03, PerformanceBridge Focal Point Version A.01, the product receives input that is expected to be well-formed (i.e., to comply with a…